Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NYSE American - Delayed Quote USD

NeurAxis, Inc. (NRXS)

Compare
1.6000
-0.0200
(-1.23%)
At close: April 17 at 3:20:44 PM EDT

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Brian Carrico President, CEO & Director 578.38k -- 1982
Mr. Timothy Robert Henrichs Chief Financial Officer 407.14k -- 1973
Dr. Adrian Miranda Senior VP of Science & Technology and Chief Medical Officer 382.44k -- 1970
Dr. Thomas Carrico Chief Regulatory Officer and Compliance & Privacy Officer 368.91k -- 1957
Dr. Christopher Robin Brown D.D.S. Founder, Director of Innovation & Director -- -- 1954

NeurAxis, Inc.

11611 North Meridian Street
Suite 330
Carmel, IN 46032
United States
812 689 0791 https://neuraxis.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
21

Description

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. The company offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8-21 years of age with functional abdominal pain associated with irritable bowel syndrome. It sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.

Corporate Governance

NeurAxis, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

April 14, 2025 at 12:00 AM UTC

DEFA14A: Proxy Statements

April 4, 2025 at 12:00 AM UTC

PRE 14A: Proxy Statements

March 20, 2025 at 12:00 AM UTC

10-K: Periodic Financial Reports

February 7, 2025 at 12:00 AM UTC

CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission

February 5, 2025 at 12:00 AM UTC

S-3/A: Offering Registrations

January 8, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

December 13, 2024 at 12:00 AM UTC

S-3: Offering Registrations

November 25, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 21, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 15, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers